Interaction of stellate cells with pancreatic carcinoma cells

Cancers

Volumn 2, Issue 3, 2010, Pages 1661-1682

  Habisch, Hansjörg ^a   Zhou, Shaoxia ^a   Siech, Marco ^b   Bachem, Max G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Ostalbklinikum Aalen ^*  (Germany)

Author keywords

Chemoresistance; EMMPRIN; Pancreas carcinoma; Pancreatic stellate cell; Tumor desmoplasia

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD147 ANTIGEN; DESMIN; ETOPOSIDE; GELATINASE A; GEMCITABINE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOL;

ANOIKIS; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOMA CELL; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; PANCREAS CARCINOMA; PANCREATIC STELLATE CELL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 79952267750     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers2031661     Document Type: Review

References (119)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225-249.
2. Cleary, S.P.; Gryfe, R.; Guindi, M.; Greig, P.; Smith, L.; Mackenzie, R.; Strasberg, S.; Hanna, S.; Taylor, B.; Langer, B.; Gallinger, S. Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors. J. Am. Coll. Surg. 2004, 198, 722-731.
3. DiMagno, E.P.; Reber, H.A.; Tempero, M.A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999, 117, 1464-1484.
4. Brand, R.E.; Tempero, M.A. Pancreatic cancer. Curr. Opin. Oncol. 1998, 10, 362-366.
5. Warshaw, A.L.; Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med. 1992, 326, 455-465.
6. A. Solid carcinomas of the exocrine pancreas. In Pathology of the Pancreas; Springer-Verlag: London, UK, 1986; pp. 155-177.
7. Pandol, S.; Edderkaoui, M.; Gukovsky, I.; Lugea, A.; Gukovskaya, A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin. Gastroenterol. Hepatol. 2009, 7, S44-S47.
8. Imamura, T.; Iguchi, H.; Manabe, T.; Ohshio, G.; Yoshimura, T.; Wang, Z.H.; Suwa, H.; Ishigami, S.; Imamura, M. Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis. Pancreas 1995, 11, 357-364.
9. Gress, T.M.; Muller-Pillasch, F.; Lerch, M.M.; Friess, H.; Buchler, M.; Adler, G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer 1995, 62, 407-413.
10. Yen, T.W.; Aardal, N.P.; Bronner, M.P.; Thorning, D.R.; Savard, C.E.; Lee, S.P.; Bell, R.H., Jr. Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 2002, 131, 129-134.
11. Apte, M.V.; Park, S.; Phillips, P.A.; Santucci, N.; Goldstein, D.; Kumar, R.K.; Ramm, G.A.; Buchler, M.; Friess, H.; McCarroll, J.A.; Keogh, G.; Merrett, N.; Pirola, R.; Wilson, J.S. Desmoplastic reaction in pancreatic cancer: Role of pancreatic stellate cells. Pancreas 2004, 29, 179-187.
12. Yoshida, S.; Yokota, T.; Ujiki, M.; Ding, X.Z.; Pelham, C.; Adrian, T.E.; Talamonti, M.S.; Bell, R.H., Jr.; Denham, W. Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem. Biophys. Res. Commun. 2004, 323, 1241-1245.
13. Bachem, M.G.; Schunemann, M.; Ramadani, M.; Siech, M.; Beger, H.; Buck, A.; Zhou, S.; Schmid-Kotsas, A.; Adler, G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005, 128, 907-921.
14. Farrow, B.; Rowley, D.; Dang, T.; Berger, D.H. Characterization of tumor-derived pancreatic stellate cells. J. Surg. Res. 2009, 157, 96-102.
15. Saotome, T.; Inoue, H.; Fujimiya, M.; Fujiyama, Y.; Bamba, T. Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas 1997, 14, 373-382.
16. Apte, M.V.; Haber, P.S.; Applegate, T.L.; Norton, I.D.; McCaughan, G.W.; Korsten, M.A.; Pirola, R.C.; Wilson, J.S. Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture. Gut 1998, 43, 128-133.
17. Bachem, M.G.; Schneider, E.; Gross, H.; Weidenbach, H.; Schmid, R.M.; Menke, A.; Siech, M.; Beger, H.; Grunert, A.; Adler, G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115, 421-432.
18. Omary, M.B.; Lugea, A.; Lowe, A.W.; Pandol, S.J. The pancreatic stellate cell: A star on the rise in pancreatic diseases. J. Clin. Invest. 2007, 117, 50-59.
19. Buchholz, M.; Kestler, H.A.; Holzmann, K.; Ellenrieder, V.; Schneiderhan, W.; Siech, M.; Adler, G.; Bachem, M.G.; Gress, T.M. Transcriptome analysis of human hepatic and pancreatic stellate cells: Organ-specific variations of a common transcriptional phenotype. J. Mol. Med. 2005, 83, 795-805.
20. Friedman, S.L. Stellate cells: A moving target in hepatic fibrogenesis. Hepatology 2004, 40, 1041-1043.
21. Gressner, A.M.; Bachem, M.G. Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells. Digestion 1995, 56, 335-346.
22. Watari, N.; Hotta, Y.; Mabuchi, Y. Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration. Okajimas Folia Anat. Jpn. 1982, 58, 837-858.
23. N. The vitamin A-storing cells in the human and rat pancreas. Kurume Med. J. 1990, 37, 67-81.
24. Bachem, M.G.; Zhou, S.; Buck, K.; Schneiderhan, W.; Siech, M. Pancreatic stellate cells--role in pancreas cancer. Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 2008, 393, 891-900.
25. Siech, M.; Zhou, Z.; Zhou, S.; Bair, B.; Alt, A.; Hamm, S.; Gross, H.; Mayer, J.; Beger, H.G.; Tian, X.; Kornmann, M.; Bachem, M.G. Stimulation of stellate cells by injured acinar cells: A model of acute pancreatitis induced by alcohol and fat (VLDL). Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G1163-G1171.
26. Phillips, P.A.; McCarroll, J.A.; Park, S.; Wu, M.J.; Pirola, R.; Korsten, M.; Wilson, J.S.; Apte, M.V. Rat pancreatic stellate cells secrete matrix metalloproteinases: Implications for extracellular matrix turnover. Gut 2003, 52, 275-282.
27. Bachem, M.G.; Zhou, Z.; Zhou, S.; Siech, M. Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J. Gastroenterol. Hepatol. 2006, 21, S92-96.
28. Sparmann, G.; Glass, A.; Brock, P.; Jaster, R.; Koczan, D.; Thiesen, H.J.; Liebe, S.; Emmrich, J. Inhibition of lymphocyte apoptosis by pancreatic stellate cells: Impact of interleukin-15. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289, G842-851.
29. Marrache, F.; Pendyala, S.; Bhagat, G.; Betz, K.S.; Song, Z.; Wang, T.C. Role of bone marrow-derived cells in experimental chronic pancreatitis. Gut 2008, 57, 1113-1120.
30. Watanabe, A.; Yoneda, M.; Ikeda, F.; Terao-Muto, Y.; Sato, H.; Kai, C. CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J. Virol. 2010, 84, 4183-4193.
31. Kordes, C.; Sawitza, I.; Haussinger, D. Hepatic and pancreatic stellate cells in focus. Biol. Chem. 2009, 390, 1003-1012.
32. Mato, E.; Lucas, M.; Petriz, J.; Gomis, R.; Novials, A. Identification of a pancreatic stellate cell population with properties of progenitor cells: New role for stellate cells in the pancreas. Biochem. J. 2009, 421, 181-191.
33. Pan, J.J.; Oh, S.H.; Lee, W.C.; Petersen, B.E. Bone marrow-derived progenitor cells could modulate pancreatic cancer tumorigenesis via peritumoral microenvironment in a rat model. Oncol. Res. 2009, 17, 339-345.
34. Guerra, C.; Schuhmacher, A.J.; Canamero, M.; Grippo, P.J.; Verdaguer, L.; Perez-Gallego, L.; Dubus, P.; Sandgren, E.P.; Barbacid, M. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007, 11, 291-302.
35. Lowenfels, A.B.; Maisonneuve, P.; Cavallini, G.; Ammann, R.W.; Lankisch, P.G.; Andersen, J.R.; Dimagno, E.P.; Andren-Sandberg, A.; Domellof, L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 1993, 328, 1433-1437.
36. Malka, D.; Hammel, P.; Maire, F.; Rufat, P.; Madeira, I.; Pessione, F.; Levy, P.; Ruszniewski, P. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002, 51, 849-852.
37. Carriere, C.; Young, A.L.; Gunn, J.R.; Longnecker, D.S.; Korc, M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 2009, 382, 561-565.
38. Nakashima, H.; Nakamura, M.; Yamaguchi, H.; Yamanaka, N.; Akiyoshi, T.; Koga, K.; Yamaguchi, K.; Tsuneyoshi, M.; Tanaka, M.; Katano, M. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 2006, 66, 7041-7049.
39. Pasca di Magliano, M.; Sekine, S.; Ermilov, A.; Ferris, J.; Dlugosz, A.A.; Hebrok, M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 2006, 20, 3161-3173.
40. Thayer, S.P.; di Magliano, M.P.; Heiser, P.W.; Nielsen, C.M.; Roberts, D.J.; Lauwers, G.Y.; Qi, Y.P.; Gysin, S.; Fernandez-del Castillo, C.; Yajnik, V.; Antoniu, B.; McMahon, M.; Warshaw, A.L.; Hebrok, M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425, 851-856.
41. De La, O.J.; Emerson, L.L.; Goodman, J.L.; Froebe, S.C.; Illum, B.E.; Curtis, A.B.; Murtaugh, L.C. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 2008, 105, 18907-18912.
42. Miyamoto, Y.; Maitra, A.; Ghosh, B.; Zechner, U.; Argani, P.; Iacobuzio-Donahue, C.A.; Sriuranpong, V.; Iso, T.; Meszoely, I.M.; Wolfe, M.S.; Hruban, R.H.; Ball, D.W.; Schmid, R.M.; Leach, S.D. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003, 3, 565-576.
43. Siveke, J.T.; Einwachter, H.; Sipos, B.; Lubeseder-Martellato, C.; Kloppel, G.; Schmid, R.M. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007, 12, 266-279.
44. Erkan, M.; Michalski, C.W.; Rieder, S.; Reiser-Erkan, C.; Abiatari, I.; Kolb, A.; Giese, N.A.; Esposito, I.; Friess, H.; Kleeff, J. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin. Gastroenterol. Hepatol. 2008, 6, 1155-1161.
45. Bonner-Weir, S.; Sharma, A. Pancreatic stem cells. J. Pathol. 2002, 197, 519-526.
46. Esposito, I.; Seiler, C.; Bergmann, F.; Kleeff, J.; Friess, H.; Schirmacher, P. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 2007, 35, 212-217.
47. Stanger, B.Z.; Stiles, B.; Lauwers, G.Y.; Bardeesy, N.; Mendoza, M.; Wang, Y.; Greenwood, A.; Cheng, K.H.; McLaughlin, M.; Brown, D.; Depinho, R.A.; Wu, H.; Melton, D.A.; Dor, Y. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 2005, 8, 185-195.
48. Habbe, N.; Shi, G.; Meguid, R.A.; Fendrich, V.; Esni, F.; Chen, H.; Feldmann, G.; Stoffers, D.A.; Konieczny, S.F.; Leach, S.D.; Maitra, A. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl. Acad. Sci. USA 2008, 105, 18913-18918.
49. Morris, J.P.T.; Cano, D.A.; Sekine, S.; Wang, S.C.; Hebrok, M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest. 2010, 120, 508-520.
50. Zhu, L.; Shi, G.; Schmidt, C.M.; Hruban, R.H.; Konieczny, S.F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am. J. Pathol. 2007, 171, 263-273.
51. Vonlaufen, A.; Phillips, P.A.; Xu, Z.; Goldstein, D.; Pirola, R.C.; Wilson, J.S.; Apte, M.V. Pancreatic stellate cells and pancreatic cancer cells: An unholy alliance. Cancer Res. 2008, 68, 7707-7710.
52. Koenig, A.; Mueller, C.; Hasel, C.; Adler, G.; Menke, A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006, 66, 4662-4671.
53. Shintani, Y.; Hollingsworth, M.A.; Wheelock, M.J.; Johnson, K.R. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res. 2006, 66, 11745-11753.
54. Tahara, J.; Shimizu, K.; Shiratori, K. Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas 2008, 37, 69-74.
55. Morishita, K.; Shimizu, K.; Haruta, I.; Kawamura, S.; Kobayashi, M.; Shiratori, K. Engulfment of Gram-Positive Bacteria by Pancreatic Stellate Cells in Pancreatic Fibrosis. Pancreas 2010, doi: 10.1097/MPA.0b013e3181d7ace1.
56. Lowenfels, A.B.; Maisonneuve, P. Risk factors for pancreatic cancer. J. Cell Biochem. 2005, 95, 649-656.
57. Farrow, B.; Albo, D.; Berger, D.H. The role of the tumor microenvironment in the progression of pancreatic cancer. J. Surg. Res. 2008, 149, 319-328.
58. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
59. Liotta, L.A.; Kohn, E.C. The microenvironment of the tumour-host interface. Nature 2001, 411, 375-379.
60. Wernert, N. The multiple roles of tumour stroma. Virchows Arch. 1997, 430, 433-443.
61. Ramachandran, V.; Arumugam, T.; Langley, R.; Hwang, R.F.; Vivas-Mejia, P.; Sood, A.K.; Lopez-Berestein, G.; Logsdon, C.D. The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PloS ONE 2009, 4, e7502.
62. Farrow, B.; Berger, D.H.; Rowley, D. Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2. J. Surg. Res. 2009, 156, 155-160.
63. Schneiderhan, W.; Diaz, F.; Fundel, M.; Zhou, S.; Siech, M.; Hasel, C.; Moller, P.; Gschwend, J.E.; Seufferlein, T.; Gress, T.; Adler, G.; Bachem, M.G. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J. Cell Sci. 2007, 120, 512-519.
64. Keleg, S.; Buchler, P.; Ludwig, R.; Buchler, M.W.; Friess, H. Invasion and metastasis in pancreatic cancer. Mol. Cancer 2003, 2, 14.
65. Bacac, M.; Stamenkovic, I. Metastatic cancer cell. Ann. Rev. Pathol. 2008, 3, 221-247.
66. Zucker, S.; Cao, J.; Chen, W.T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000, 19, 6642-6650.
67. Overall, C.M.; Kleifeld, O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br. J. Cancer 2006, 94, 941-946.
68. Zucker, S.; Cao, J. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time? Cancer Biol. Ther. 2009, 8, 2371-2373.
69. Zhang, W.; Erkan, M.; Abiatari, I.; Giese, N.A.; Felix, K.; Kayed, H.; Buchler, M.W.; Friess, H.; Kleeff, J. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells. Cancer Biol. Ther. 2007, 6, 218-227.
70. Dang, D.; Atakilit, A.; Ramos, D.M. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Anticancer Res. 2008, 28, 2049-2054.
71. Hanata, K.; Yamaguchi, N.; Yoshikawa, K.; Mezaki, Y.; Miura, M.; Suzuki, S.; Senoo, H.; Ishikawa, K. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts. Arch. Histol. Cytol. 2007, 70, 267-277.
72. Kanekura, T.; Chen, X.; Kanzaki, T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int. J. Cancer 2002, 99, 520-528.
73. Qian, A.R.; Zhang, W.; Cao, J.P.; Yang, P.F.; Gao, X.; Wang, Z.; Xu, H.Y.; Weng, Y.Y.; Shang, P. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. J. Exp. Clin. Cancer Res 2008, 27, 50.
74. Marieb, E.A.; Zoltan-Jones, A.; Li, R.; Misra, S.; Ghatak, S.; Cao, J.; Zucker, S.; Toole, B.P. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 2004, 64, 1229-1232.
75. Yang, J.M.; O'Neill, P.; Jin, W.; Foty, R.; Medina, D.J.; Xu, Z.; Lomas, M.; Arndt, G.M.; Tang, Y.; Nakada, M.; Yan, L.; Hait, W.N. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J. Biol. Chem. 2006, 281, 9719-9727.
76. Tang, Y.; Nakada, M.T.; Kesavan, P.; McCabe, F.; Millar, H.; Rafferty, P.; Bugelski, P.; Yan, L. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 2005, 65, 3193-3199.
77. Voigt, H.; Vetter-Kauczok, C.S.; Schrama, D.; Hofmann, U.B.; Becker, J.C.; Houben, R. CD147 impacts angiogenesis and metastasis formation. Cancer Invest. 2009, 27, 329-333.
78. Zheng, H.C.; Takahashi, H.; Murai, Y.; Cui, Z.G.; Nomoto, K.; Miwa, S.; Tsuneyama, K.; Takano, Y. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: A good marker for local invasion and prognosis. Br. J. Cancer 2006, 95, 1371-1378.
79. Li, Q.Q.; Wang, W.J.; Xu, J.D.; Cao, X.X.; Chen, Q.; Yang, J.M.; Xu, Z.D. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci. 2007, 98, 1064-1069.
80. Toole, B.P.; Slomiany, M.G. Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance. Drug Resist. Update 2008, 11, 110-121.
81. Nabeshima, K.; Iwasaki, H.; Koga, K.; Hojo, H.; Suzumiya, J.; Kikuchi, M. Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol. Int. 2006, 56, 359-367.
82. Schneiderhan, W.; Scheler, M.; Holzmann, K.H.; Marx, M.; Gschwend, J.E.; Buchholz, M.; Gress, T.M.; Adler, G.; Seufferlein, T.; Oswald, F. CD147 Silencing Inhibits Lactate Transport and Reduces Malignant Potential of pancreatic cancer cells in in vivo and in vitro Models. Gut 2009, 58, 1391-1398.
83. Dalberg, K.; Eriksson, E.; Enberg, U.; Kjellman, M.; Backdahl, M. Gelatinase A. membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer. World J. Surg. 2000, 24, 334-340.
84. Zhong, W.D.; Han, Z.D.; He, H.C.; Bi, X.C.; Dai, Q.S.; Zhu, G.; Ye, Y.K.; Liang, Y.X.; Qin, W.J.; Zhang, Z.; Zeng, G.H.; Chen, Z.N. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 2008, 75, 230-236.
85. Li, R.; Huang, L.; Guo, H.; Toole, B.P. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J. Cell Physiol. 2001, 186, 371-379.
86. Sun, J.; Hemler, M.E. Regulation of MMP-1 and MMP-2 production through CD147/ extracellular matrix metalloproteinase inducer interactions. Cancer Res. 2001, 61, 2276-2281.
87. Tang, Y.; Kesavan, P.; Nakada, M.T.; Yan, L. Tumor-stroma interaction: Positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol. Cancer Res. 2004, 2, 73-80.
88. Chen, X.; Lin, J.; Kanekura, T.; Su, J.; Lin, W.; Xie, H.; Wu, Y.; Li, J.; Chen, M.; Chang, J. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res. 2006, 66, 11323-11330.
89. Dean, N.R.; Newman, J.R.; Helman, E.E.; Zhang, W.; Safavy, S.; Weeks, D.M.; Cunningham, M.; Snyder, L.A.; Tang, Y.; Yan, L.; McNally, L.R.; Buchsbaum, D.J.; Rosenthal, E.L. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin. Cancer Res. 2009, 15, 4058-4065.
90. Voigt, H.; Houben, R.; Schrama, D.; Hofmann, U.B.; Vetter-Kauczok, C.S.; Becker, J.C. Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma. Tumour Biol. 2007, 28, 229-237.
91. Tang, W.; Chang, S.B.; Hemler, M.E. Links between CD147 function, glycosylation, and caveolin-1. Mol. Biol. Cell 2004, 15, 4043-4050.
92. Millimaggi, D.; Mari, M.; D'Ascenzo, S.; Carosa, E.; Jannini, E.A.; Zucker, S.; Carta, G.; Pavan, A.; Dolo, V. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia N. Y. 2007, 9, 349-357.
93. Sidhu, S.S.; Mengistab, A.T.; Tauscher, A.N.; LaVail, J.; Basbaum, C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 2004, 23, 956-963.
94. Haug, C.; Lenz, C.; Diaz, F.; Bachem, M.G. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1823-1829.
95. Belton, R.J., Jr.; Chen, L.; Mesquita, F.S.; Nowak, R.A. Basigin-2 is a cell surface receptor for soluble basigin ligand. J. Biol. Chem. 2008, 283, 17805-17814.
96. Lim, M.; Martinez, T.; Jablons, D.; Cameron, R.; Guo, H.; Toole, B.; Li, J.D.; Basbaum, C. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 1998, 441, 88-92.
97. Taylor, P.M.; Woodfield, R.J.; Hodgkin, M.N.; Pettitt, T.R.; Martin, A.; Kerr, D.J.; Wakelam, M.J. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 2002, 21, 5765-5772.
98. Warburg, O. On the origin of cancer cells. Science 1956, 123, 309-314.
99. Guo, H.; Li, R.; Zucker, S.; Toole, B.P. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 2000, 60, 888-891.
100. Sternlicht, M.D.; Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 2001, 17, 463-516.
101. Bramhall, S.R.; Neoptolemos, J.P.; Stamp, G.W.; Lemoine, N.R. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J. Pathol. 1997, 182, 347-355.
102. Hwang, R.F.; Moore, T.; Arumugam, T.; Ramachandran, V.; Amos, K.D.; Rivera, A.; Ji, B.; Evans, D.B.; Logsdon, C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68, 918-926.
103. Gao, Z.; Wang, X.; Wu, K.; Zhao, Y.; Hu, G. Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis. Pancreatology 2010, 10, 186-193.
104. Vonlaufen, A.; Joshi, S.; Qu, C.; Phillips, P.A.; Xu, Z.; Parker, N.R.; Toi, C.S.; Pirola, R.C.; Wilson, J.S.; Goldstein, D.; Apte, M.V. Pancreatic stellate cells: Partners in crime with pancreatic cancer cells. Cancer Res. 2008, 68, 2085-2093.
105. Fujita, H.; Ohuchida, K.; Mizumoto, K.; Egami, T.; Miyoshi, K.; Moriyama, T.; Cui, L.; Yu, J.; Zhao, M.; Manabe, T.; Tanaka, M. Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci. 2009, 100, 2309-2317.
106. Korc, M. Pancreatic cancer-associated stroma production. Am. J. Surg. 2007, 194, S84-86.
107. Giovannetti, E.; Del Tacca, M.; Mey, V.; Funel, N.; Nannizzi, S.; Ricci, S.; Orlandini, C.; Boggi, U.; Campani, D.; Del Chiaro, M.; Iannopollo, M.; Bevilacqua, G.; Mosca, F.; Danesi, R. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res. 2006, 66, 3928-3935.
108. Giovannetti, E.; Mey, V.; Nannizzi, S.; Pasqualetti, G.; Del Tacca, M.; Danesi, R. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Mol. Cancer Ther. 2006, 5, 1387-1395.
109. Shi, X.; Liu, S.; Kleeff, J.; Friess, H.; Buchler, M.W. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology 2002, 62, 354-362.
110. Wang, C.Y.; Cusack, J.C., Jr.; Liu, R.; Baldwin, A.S., Jr. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nature Medicine 1999, 5, 412-417.
111. Arlt, A.; Vorndamm, J.; Breitenbroich, M.; Folsch, U.R.; Kalthoff, H.; Schmidt, W.E.; Schafer, H. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 2001, 20, 859-868.
112. Muerkoster, S.; Wegehenkel, K.; Arlt, A.; Witt, M.; Sipos, B.; Kruse, M.L.; Sebens, T.; Kloppel, G.; Kalthoff, H.; Folsch, U.R.; Schafer, H. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res. 2004, 64, 1331-1337.
113. Muerkoster, S.S.; Werbing, V.; Koch, D.; Sipos, B.; Ammerpohl, O.; Kalthoff, H.; Tsao, M.S.; Folsch, U.R.; Schafer, H. Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases. Int. J. Cancer 2008, 123, 1751-1760.
114. Miyamoto, H.; Murakami, T.; Tsuchida, K.; Sugino, H.; Miyake, H.; Tashiro, S. Tumor-stroma interaction of human pancreatic cancer: Acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004, 28, 38-44.
115. Tannock, I.F.; Lee, C.M.; Tunggal, J.K.; Cowan, D.S.; Egorin, M.J. Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy. Clin. Cancer Res. 2002, 8, 878-884.
116. Stander, M.; Naumann, U.; Wick, W.; Weller, M. Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999, 296, 221-227.
117. Koninger, J.; Giese, N.A.; di Mola, F.F.; Berberat, P.; Giese, T.; Esposito, I.; Bachem, M.G.; Buchler, M.W.; Friess, H. Overexpressed decorin in pancreatic cancer: Potential tumor growth inhibition and attenuation of chemotherapeutic action. Clin. Cancer. Res. 2004, 10, 4776-4783.
118. Olive, K.P.; Jacobetz, M.A.; Davidson, C.J.; Gopinathan, A.; McIntyre, D.; Honess, D.; Madhu, B.; Goldgraben, M.A.; Caldwell, M.E.; Allard, D.; Frese, K.K.; Denicola, G.; Feig, C.; Combs, C.; Winter, S.P.; Ireland-Zecchini, H.; Reichelt, S.; Howat, W.J.; Chang, A.; Dhara, M.; Wang, L.; Ruckert, F.; Grutzmann, R.; Pilarsky, C.; Izeradjene, K.; Hingorani, S.R.; Huang, P.; Davies, S.E.; Plunkett, W.; Egorin, M.; Hruban, R.H.; Whitebread, N.; McGovern, K.; Adams, J.; Iacobuzio-Donahue, C.; Griffiths, J.; Tuveson, D.A. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324, 1457-1461.
119. Kim, N.; Choi, S.; Lim, C.; Lee, H.; Oh, J. Albumin mediates PPAR-gamma or C/EBP-alpha-induced phenotypic changes in pancreatic stellate cells. Biochem. Biophys. Res. Commun. 2010, 391, 640-644.